ClinicalTrials.gg
CompletedNCT00150410Updated Oct 31, 2008

Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose

A Phase 3 interventional study of Inhaled insulin in Diabetes Mellitus, sponsored by Pfizer. Completed at 120 sites in 5 countries. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2008-10-31.

Sponsored by Pfizer · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
626
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 51 studies testing insulin in Diabetes Mellitus — 1 open to participants now, 2 under way, none of them phase 3. Insulin · Diabetes Mellitus.

Enrollment
7th of 49
626 · median 74
Started
2003
with 3 others
Phase 3
11 of 51
none open now
Registered
7th of 51
by date
Lead sponsor
5 of 51
Pfizer

Among the 51 studies testing insulin in Diabetes Mellitus, this one is the 7th largest by enrollment of the 49 interventional ones that give a count, is one of 4 that started in 2003, is one of 11 in phase 3, and was the 7th registered.

Diabetes Mellitus

8,293 studies on the registry are indexed under Diabetes Mellitus; 1,072 are open to participants now.

Browse Diabetes Mellitus studies →

Open to participants now

1 of the 51 studies testing insulin in Diabetes Mellitus is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

About insulin

No approval found in the FDA or EMA files read. How studies give it is on its page →

Who these studies take

Of the 648 Diabetes Mellitus studies recruiting now, 357 (55%) set no upper age limit and 195 (30%) stop at 75 or younger; 88 take children under 18; 182 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 51 studies testing insulin in Diabetes Mellitus, or all of them as a file.
02

Study summary

  • Whether a combination of three therapies - metformin and a sulfonylurea plus Exubera, an investigational drug, controls your diabetes at least as much as a triple combination therapy of metformin and a sulfonylurea plus Avandia, a Food and Drug Administration (FDA) approved drug.
  • Whether a combination of two therapies - metformin plus Exubera controls your diabetes at least as much as a as a triple combination therapy of metformin and a sulfonylurea plus Avandia.
03

Conditions studied

  • Diabetes Mellitus

Browse trials for

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Type 2 diabetes
  • Currently treated and on a stable doses of drugs for the preceding two (2) months

Exclusion criteria

Exclusion Criteria:

  • Type 1 Diabetes
  • Smoking
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
626 participants (actual)

Interventions

06

What researchers measure

Primary outcomes

  1. Glycosylated hemoglobin

Secondary outcomes

  1. Change from baseline in fasting plasma glucose. Other secondary efficacy

  2. endpoints include, body weight, patient reported outcomes, incidence and severity

  3. of hypoglycemic episodes, cough questionnaire, and discontinuation rate due to

  4. insufficient clinical response.

07

Study locations

120 sites
  • Pfizer Investigational Site
    Mesa, Arizona 85205, United States
  • Pfizer Investigational Site
    Phoenix, Arizona 85012, United States
  • Pfizer Investigational Site
    Tucson, Arizona 85715, United States
  • Pfizer Investigational Site
    Searcy, Arkansas 72143, United States
  • Pfizer Investigational Site
    Alhambra, California 91801, United States
  • Pfizer Investigational Site
    Concord, California 94520, United States
  • Pfizer Investigational Site
    Huntington Beach, California 92647, United States
  • Pfizer Investigational Site
    Huntington Beach, California 92648, United States
  • Pfizer Investigational Site
    La Jolla, California 92037, United States
  • Pfizer Investigational Site
    Long Beach, California 90805, United States
  • Pfizer Investigational Site
    Long Beach, California 90806, United States
  • Pfizer Investigational Site
    Los Angeles, California 90048, United States
  • Pfizer Investigational Site
    Riverside, California 92506, United States
  • Pfizer Investigational Site
    Santa Barbara, California 93105, United States
  • Pfizer Investigational Site
    Tustin, California 92780, United States
  • Pfizer Investigational Site
    Westminster, California 92683, United States
  • Pfizer Investigational Site
    Denver, Colorado 80209, United States
  • Pfizer Investigational Site
    Wheat Ridge, Colorado 80033, United States
  • Pfizer Investigational Site
    Waterbury, Connecticut 06708, United States
  • Pfizer Investigational Site
    Washington, District of Columbia 20010, United States
  • Pfizer Investigational Site
    Washington, District of Columbia 20307, United States
  • Pfizer Investigational Site
    Hollywood, Florida 33021, United States
  • Pfizer Investigational Site
    West Palm Beach, Florida 33401, United States
  • Pfizer Investigational Site
    Winter Park, Florida 32789, United States
  • Pfizer Investigational Site
    Atlanta, Georgia 30309, United States
  • Pfizer Investigational Site
    Augusta, Georgia 30909, United States
  • Pfizer Investigational Site
    Savannah, Georgia 31405, United States
  • Pfizer Investigational Site
    Savannah, Georgia 31419, United States
  • Pfizer Investigational Site
    Ewa Beach, Hawaii 96706, United States
  • Pfizer Investigational Site
    Honolulu, Hawaii 96813, United States
  • Pfizer Investigational Site
    Idaho Falls,, Idaho 83404-7542, United States
  • Pfizer Investigational Site
    Idaho Falls, Idaho 83404-6370, United States
  • Pfizer Investigational Site
    Idaho Falls, Idaho 83404-7542, United States
  • Pfizer Investigational Site
    Chicago Heights, Illinois 60411, United States
  • Pfizer Investigational Site
    Indianapolis, Indiana 46202, United States
  • Pfizer Investigational Site
    Des Moines, Iowa 50314, United States
  • Pfizer Investigational Site
    Wichita, Kansas 67203, United States
  • Pfizer Investigational Site
    Lexington, Kentucky 40503, United States
  • Pfizer Investigational Site
    Louisville, Kentucky 40213, United States
  • Pfizer Investigational Site
    Baton Rouge, Louisiana 70808, United States
  • Pfizer Investigational Site
    New Orleans, Louisiana 70112, United States
  • Pfizer Investigational Site
    Baltimore, Maryland 21204, United States
  • Pfizer Investigational Site
    Springfield, Massachusetts 01103, United States
  • Pfizer Investigational Site
    Springfield, Massachusetts 01199, United States
  • Pfizer Investigational Site
    Waltham, Massachusetts 02453, United States
  • Pfizer Investigational Site
    West St. Paul, Minnesota 55118, United States
  • Pfizer Investigational Site
    North Kansas City, Missouri 64116, United States
  • Pfizer Investigational Site
    St. Louis, Missouri 63141, United States
  • Pfizer Investigational Site
    Butte, Montana 59701, United States
  • Pfizer Investigational Site
    Lincoln, Nebraska 68521, United States
  • Pfizer Investigational Site
    New Brunswick, New Jersey 08901, United States
  • Pfizer Investigational Site
    New Brunswick, New Jersey 08903, United States
  • Pfizer Investigational Site
    Albuquerque, New Mexico 87106, United States
  • Pfizer Investigational Site
    Albany, New York 12208, United States
  • Pfizer Investigational Site
    Flushing, New York 11365, United States
  • Pfizer Investigational Site
    Mineola, New York 11501, United States
  • Pfizer Investigational Site
    New Hyde Park, New York 11042, United States
  • Pfizer Investigational Site
    Rochester, New York 14642, United States
  • Pfizer Investigational Site
    Raleigh, North Carolina 27609, United States
  • Pfizer Investigational Site
    Cincinnati, Ohio 45229, United States
  • Pfizer Investigational Site
    Cleveland, Ohio 44195, United States
  • Pfizer Investigational Site
    Lakewood, Ohio 44107, United States
  • Pfizer Investigational Site
    Oklahoma City, Oklahoma 73104, United States
  • Pfizer Investigational Site
    Portland, Oregon 97210, United States
  • Pfizer Investigational Site
    Pittsburgh, Pennsylvania 15235, United States
  • Pfizer Investigational Site
    Charleston, South Carolina 29401-5799, United States
  • Pfizer Investigational Site
    Charleston, South Carolina 29425, United States
  • Pfizer Investigational Site
    Duncan, South Carolina 29334, United States
  • Pfizer Investigational Site
    Spartanburg, South Carolina 29303, United States
  • Pfizer Investigational Site
    Spartanburg, South Carolina 29307, United States
  • Pfizer Investigational Site
    Sumter, South Carolina 29150, United States
  • Pfizer Investigational Site
    Kingsport, Tennessee 37660, United States
  • Pfizer Investigational Site
    Knoxville, Tennessee 37909, United States
  • Pfizer Investigational Site
    Memphis, Tennessee 38119, United States
  • Pfizer Investigational Site
    Nashville, Tennessee 37232, United States
  • Pfizer Investigational Site
    Corpus Christi, Texas 78411, United States
  • Pfizer Investigational Site
    Dallas, Texas 75230, United States
  • Pfizer Investigational Site
    Dallas, Texas 75246, United States
  • Pfizer Investigational Site
    El Paso, Texas 79925, United States
  • Pfizer Investigational Site
    El Paso, Texas 79935, United States
  • Pfizer Investigational Site
    San Antonio, Texas 78229, United States
  • Pfizer Investigational Site
    San Antonio, Texas 78237, United States
  • Pfizer Investigational Site
    Ogden, Utah 84403, United States
  • Pfizer Investigational Site
    Fredericksburg, Virginia 22401, United States
  • Pfizer Investigational Site
    Richmond, Virginia 23221, United States
  • Pfizer Investigational Site
    Richmond, Virginia 23294, United States
  • Pfizer Investigational Site
    Renton, Washington 98055, United States
  • Pfizer Investigational Site
    Tukwila, Washington 98188, United States
  • Pfizer Investigational Site
    Milwaukee, Wisconsin 53209, United States
  • Pfizer Investigational Site
    Camperdown, New South Wales 2050, Australia
  • Pfizer Investigational Site
    Wollongong, New South Wales 2500, Australia
  • Pfizer Investigational Site
    Herston, Queensland 4029, Australia
  • Pfizer Investigational Site
    Woolloongabba, Queensland 4102, Australia
  • Pfizer Investigational Site
    Keswick, South Australia 5035, Australia
  • Pfizer Investigational Site
    Box Hill, Victoria 3128, Australia
  • Pfizer Investigational Site
    Caulfield, Victoria 3162, Australia
  • Pfizer Investigational Site
    Porto Alegre, RS 90035-170, Brazil
  • Pfizer Investigational Site
    Sao Paulo, SP 01244-030, Brazil
  • Pfizer Investigational Site
    Sao Paulo, SP 04231-030, Brazil
  • Pfizer Investigational Site
    Winnipeg, Manitoba R3E 3P4, Canada

Showing the first 100 of 120 sites across 5 countries. Choose a country and city above to see the rest.

08

References and documents

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2003 and a completion of Jun 2007. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2005
First posted
Sep 8, 2005
Start
Jan 2003
CompletionActual
Jun 2007
Last update
Oct 31, 2008
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 31, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00150410
Lead sponsor
Pfizer
Collaborators
Sanofi
First posted
Sep 8, 2005
Start date
Jan 2003
Completion
Jun 2007
Last update
Oct 31, 2008

Study contacts

Pfizer CT.gov Call Center
study director · Pfizer
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Insulin

Start the discussion